Thomas A. Good

812 citations
28 papers · 620 indexed · h-index 15
Topics
Hepatitis C virus research (4 papers)Glycosylation and Glycoproteins Research (3 papers)Metabolism and Genetic Disorders (3 papers)

In The Last Decade

Thomas A. Good

27 papers receiving 513 citations

Peers

Thomas A. Good
Comparison fields: 5 of 100
  • Molecular Biology 195
  • Epidemiology 126
  • Hepatology 111
  • Surgery 76
  • Rheumatology 72
Replace Frank Sinatra with:
Frank Sinatra United States
Yoshihisa Fujiura Japan
Avi Hassner Israel
A Alvarez Spain
Harrison M. Lazarus United States
D Sampson United States
K. R. Hill United Kingdom
T.C. Northfield United Kingdom
K. Dreikorn Germany
Frank C. Grenier United States
Thomas A. Good relative to Frank Sinatra United States Frank Sinatra's profile →
Citations per field
00.5×1.5×1.8×
Frank Sinatra · 1×
Citations per year

Countries citing papers authored by Thomas A. Good

Since Specialization
Citations

This map shows the geographic impact of Thomas A. Good's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Good with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Good more than expected).

Fields of papers citing papers by Thomas A. Good

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas A. Good. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Good. The network helps show where Thomas A. Good may publish in the future.

Co-authorship network of co-authors of Thomas A. Good

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas A. Good. A scholar is included among the top collaborators of Thomas A. Good based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas A. Good. Thomas A. Good is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 34
2 10
3 31
4 47
5 10
6 16
7 3
8 33
9 31
10 47
11 20
12 8
13 18
14 8
15 91
16 29
17 7
18 51
19 9
20 21

About Thomas A. Good

Thomas A. Good is a scholar working on Clinical Biochemistry, Hepatology and Physiology, having authored 28 papers that have together received 620 indexed citations. Recurring topics across this work include Hepatitis C virus research (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Metabolism and Genetic Disorders (3 papers). The work is most often cited by research in Hepatology (111 citations), Clinical Biochemistry (51 citations) and Rheumatology (72 citations). Thomas A. Good has collaborated with scholars based in United States, United Kingdom and Slovakia. Frequent co-authors include Samuel P. Bessman, Kumudchandra J. Sheth, Vincent C. Kelley, S. Cameron, Thomas T. Tang, Richard D. Richards, John W. Benton, Brendan McCarron, James T. Casper and Alan Pithie. Their work appears in journals such as PEDIATRICS, Analytical Biochemistry and Radiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026